Hugh R. Sharkey

Life Science Angels (Life Science Angels) is a venture capital subsidiary of Life Science Angels, Inc. founded in 2004 by Allan W. May, Greg B. Scott and J. Casey McGlynn. The firm is headquartered in Sunnyvale, California.

AEGEA Medical, Inc. develops technology that utilizes convective water vapor to treat menorrhagia. The firm focuses on the development of its proprietary and innovative water vapor treatment for abnormal uterine bleeding. It has vapor system delivers controlled, low-pressure natural water vapor to the uterine cavity to efficiently ablate the inner lining of the uterus. The company was founded by Paul M. Goeld in 2008 and is headquartered in Redwood City, CA.

CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA.

EMKinetics, Inc. operates as a clinical-stage medical technology company which develops neuromodulation therapies based on its percutaneous stimulation technology. It focuses on neuromodulation for the treatment of overactive bladder and other maladies. The company was founded by Daniel Rogers Burnett, Christopher Hermanson and Marshall Stoller in 2006 and is headquartered in San Francisco, CA.

SpineAlign Medical, Inc. operates as a medical device company which develops implantable products to treat vertebral compression fractures. Its nitinol implant is designed to improve the lumbar spines. The firm’s implants are designed to support vertebral endplates, reducing the fracture and maintaining lift until bone cement is injected. The company was founded by Paul E. Chirico in 2005 and is headquartered in San Jose, CA.

ORATEC Interventions, Inc. develops and markets medical devices that use controlled thermal energy to treat spine and joint disorders. The company markets two minimally invasive systems: the SpineCATH IntraDiscal ElectroThermal Therapy (IDET) system and the ElectroThermal Arthroscopy system. The company markets its products directly to orthopedic surgeons, neurosurgeons and pain management specialists.

RITA Medical Systems, Inc. develops, manufactures and markets ablation technology products used by physicians to treat patients with solid cancerous or benign tumors. The system consists of a radiofrequency energy generator and disposable accessories. The RITA systems have been approved to treat liver cancer and are sold in Asia, Europe and the US. The company develops the use of the system for the treatment of various other cancers. Investors in RITA Medical include Apax Partners and Morgan Stanley. RITA Medical is in the process of merging with Horizon Medical. RITA Medical Systems has been acquired by Angio Dynamics, inc. The company was founded in 1994 and is headquartered in Fremont, CA.